Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNX8 Inhibitors

SNX8 inhibitors represent a diverse class of chemical compounds specifically designed to modulate the activity of Sorting Nexin 8 (SNX8), a crucial protein involved in various cellular processes, predominantly intracellular membrane trafficking and endosome maturation. SNX8, a member of the Sorting Nexin (SNX) family of proteins, plays a pivotal role in regulating the sorting and trafficking of cellular cargo within the endosomal and lysosomal pathways. It primarily functions in coordinating the retrieval of membrane proteins and lipids from endosomes and directing them to their respective destinations within the cell. As a result, SNX8 serves as a key player in maintaining cellular homeostasis and proper organelle function.

The inhibitors targeting SNX8 typically exert their effects by interfering with specific aspects of its molecular machinery. Some compounds disrupt SNX8's interactions with other proteins or lipid components, impeding its ability to recognize and sort cargo molecules. Others may affect the endosomal membrane dynamics or alter the lipid composition within endosomes, thereby hampering SNX8's sorting capabilities. Additionally, certain inhibitors may interfere with the regulatory pathways or post-translational modifications that modulate SNX8 activity. By selectively inhibiting SNX8, these chemical agents serve as valuable tools for researchers aiming to dissect the intricate mechanisms governing intracellular trafficking and organelle dynamics. Moreover, they contribute to a deeper understanding of the role SNX8 plays in cellular physiology and pave the way for applications in various fields, including cell biology, membrane trafficking studies, and drug discovery endeavors targeting conditions where precise control over intracellular transport is essential.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine disrupts lysosomal function, inhibiting SNX8 and leading to impaired autophagy and endosomal trafficking.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Bafilomycin A1 inhibits the V-ATPase proton pump, blocking endosome acidification and impairing SNX8-mediated cargo sorting.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin inhibits PI3-kinase, disrupting phosphoinositide signaling pathways essential for SNX8 function in endosome maturation.

U 18666A

3039-71-2sc-203306
sc-203306A
10 mg
50 mg
$140.00
$500.00
2
(1)

U18666A inhibits cholesterol trafficking, disrupting lipid sorting by SNX8 on endosomes and impairing membrane trafficking.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$37.00
$77.00
$184.00
$510.00
$1224.00
$5814.00
8
(1)

Niclosamide inhibits SNX8 by interfering with its role in Wnt signaling, leading to the disruption of endosomal cargo sorting.

GW4869

6823-69-4sc-218578
sc-218578A
5 mg
25 mg
$199.00
$599.00
24
(3)

GW4869 inhibits sphingomyelinase, altering lipid composition in endosomes and interfering with SNX8-mediated sorting processes.

Vacuolin-1

351986-85-1sc-216045
10 mg
$260.00
29
(2)

Vacuolin-1 disrupts endosomal maturation by inhibiting SNX8, resulting in the formation of enlarged endosomal compartments.

Pitstop 2

1419093-54-1sc-507418
10 mg
$360.00
(0)

Pitstop 2 inhibits clathrin-mediated endocytosis, indirectly affecting SNX8-mediated cargo sorting on clathrin-coated vesicles.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Dynasore inhibits dynamin, interfering with endocytic vesicle scission and indirectly impacting SNX8-mediated cargo sorting.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

SAR405 inhibits PI3-kinase, disrupting phosphoinositide signaling pathways involved in SNX8-mediated endosomal cargo sorting.